Story

Hims & Hers Stock Tumbles as Margin Contraction Overshadows Revenue Beat

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20261 min read
Hims & Hers Stock Tumbles as Margin Contraction Overshadows Revenue Beat
Text size
Background

Shares of Hims & Hers Health (NYSE: HIMS) fell more than 7% in premarket trading after the telehealth company's second-quarter results highlighted a growing conflict between rapid sales growth and declining profitability. While revenue significantly surpassed expectations, a sharp contraction in gross margins led to a wider-than-expected loss per share.

Revenue Growth vs. Margin Pressure

Hims & Hers reported impressive top-line performance for the second quarter, with revenue growing 38% year-over-year to $753 million, beating analyst estimates by nearly 9%. The company also raised its full-year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion and added over 300,000 subscribers, bringing its total to almost 2.9 million.

However, this growth came at a significant cost to profitability. Gross margin fell to 64%, a steep decline from 82% in the same period in 2023 and the fourth consecutive quarterly drop. According to CFO Oluyemi Okupe, the margin compression is a direct result of a strategic shift towards higher-cost offerings, including branded GLP-1 weight-loss drugs and international revenue from its Eucalyptus acquisition.

Sample IUX Markets – In-articleAd

Legal and Valuation Concerns

Adding to investor concerns, the company is facing legal challenges. The U.S. Federal Trade Commission (FTC) filed a lawsuit on July 29, alleging that Hims & Hers shared sensitive user health data with third-party advertising platforms like Meta and Snap. The complaint also raises issues with the company's billing and cancellation processes.

The company's valuation remains a point of contention amid its unprofitability. Hims & Hers posted a net loss of $86.3 million for the quarter, or -$0.37 per share, missing consensus estimates by $0.32. The stock's high valuation multiples and a debt-to-equity ratio of over 250% are also being scrutinized by the market, particularly as margins continue to trend downward.

Read next

More on Stocks
Back to latest news

LATEST